Hemodialysis Access Dysfunction
📧 Sign up to get email alerts when something new happens for Hemodialysis Access Dysfunction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Ascorbic Acid on Restenosis of Dysfunctional Hemodialysis Vascular Access [Phase 2]
A Phase 2 clinical trial evaluating ascorbic acid for restenosis in dysfunctional hemodialysis vascular access has completed.